Difference between revisions of "Pathology for medical students"

Jump to navigation Jump to search
 
(2 intermediate revisions by the same user not shown)
Line 61: Line 61:
*[[Immunohistochemical stains]].
*[[Immunohistochemical stains]].
**[[Cancers of unknown primary]].
**[[Cancers of unknown primary]].
*Targeted therapies.
*Targeted therapies/molecular testing:
**Receptors in breast cancer.
**Receptors in breast cancer (ER, PR, HER2).
**Lung cancer biomarkers ([[Lung_carcinoma_with_EGFR_mutation|EGFR]], [[Lung carcinoma with ALK rearrangement|ALK]], [[PD-L1]], [[ROS1-rearranged non-small cell lung carcinoma|ROS1]]).
**BRAF testing in [[malignant melanoma]].
**[[Microsatellite instability in colorectal cancer|MSI testing]] in [[colorectal cancer]].


==See also==
==See also==
48,479

edits

Navigation menu